 | Up a level |
Wirsching, H-G; Tabatabai, G; Roelcke, U; Hottinger, A F; Jörger, F; Schmid, A; Plasswilm, Ludwig; Schrimpf, D; Mancao, C; Capper, D; Conen, K; Hundsberger, T; Caparrotti, F; von Moos, R; Riklin, C; Felsberg, J; Roth, P; Jones, D T W; Pfister, S; Rushing, E J; ... (2018). Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Annals of oncology, 29(6), pp. 1423-1430. Oxford University Press 10.1093/annonc/mdy120
Wei, W; Schüpbach, Gertraud; Held, L (2015). Time-series analysis of Campylobacter incidence in Switzerland. Epidemiology and infection, 143(09), pp. 1982-1989. Cambridge University Press 10.1017/S0950268814002738
Huber, M; Ledergerber, B; Sauter, R; Young, J; Fehr, J; Cusini, A; Battegay, M; Calmy, A; Orasch, C; Nicca, D; Bernasconi, E; Jaccard, R; Held, L; Weber, R; Swiss HIV Cohort Study Group, (2012). Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV medicine, 13(7), pp. 387-397. Oxford: Blackwell Science 10.1111/j.1468-1293.2011.00984.x
Herzog, S A; Paul, M; Held, L (2011). Heterogeneity in vaccination coverage explains the size and occurrence of measles epidemics in German surveillance data. Epidemiology and infection, 139(4), pp. 505-515. Cambridge: Cambridge University Press 10.1017/S0950268810001664
